[Sildenafil influence on the level of pulmonary artery pressure, bronchial patency and endothelial function during the action of risk factors for development of cardiorespiratory pathology].
Baksheev
V I
VI
Kolomoets
N M
NM
Kartashov
V T
VT
Tursunova
G F
GF
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004727:Endothelium / Q000187:drug effects; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000503:physiopathology; D006801:Humans; D008297:Male; D010865:Pilot Projects; D010879:Piperazines / Q000627:therapeutic use*; D011651:Pulmonary Artery / Q000187:drug effects; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D011687:Purines / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use*; D016896:Treatment Outcome; D014463:Ultrasonography; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate